Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82851-82900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05195645
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
PHASE2Active, not recruiting
21 participants
Started: Oct 4, 2022 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT05467176
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
N/AActive, not recruiting
999 participants
Started: Oct 4, 2022 · Completed: May 31, 2028
1 condition1 sponsor96 locations
NCT05539573
PROVE ACURATE neo2™ - Post Market Safety and Performance Surveillance in Aortic Stenosis
N/AActive, not recruiting
1,043 participants
Started: Oct 4, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors27 locations
NCT05617001
Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)
NARecruiting
200 participants
Started: Oct 4, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
N/ARecruiting
700 participants
Started: Oct 4, 2022 · Completed: Apr 28, 2028
1 condition2 sponsors64 locations
NCT06698094
Sustainable Office Intervention, Impact of a Sustainable Lifestyle on Diet, Physical Activity and Carbon Footprint
NAActive, not recruiting
90 participants
Started: Oct 4, 2022 · Completed: Dec 24, 2026
2 conditions2 sponsors1 location
NCT05710172
Evaluation of Auditory Mirror-therapy for Tinnitus
NAActive, not recruiting
50 participants
Started: Oct 4, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05573048
A Study of Optical Fusion Trans-Perineal Grid
NAEnrolling by invitation
20 participants
Started: Oct 4, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05332301
Sex Differences in Metabolism Following a High-fat Meal
NARecruiting
24 participants
Started: Oct 4, 2022 · Completed: May 30, 2027
1 condition2 sponsors1 location
NCT05453903
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
PHASE1Recruiting
200 participants
Started: Oct 4, 2022 · Completed: Mar 19, 2027
1 condition1 sponsor32 locations
NCT06116032
Immune Profiling for Cancer Immunotherapy Response
N/ARecruiting
1,500 participants
Started: Oct 3, 2022 · Completed: Jan 1, 2026
4 conditions1 sponsor1 location
NCT04922723
Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Oct 3, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05961644
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
PHASE2/PHASE3Recruiting
188 participants
Started: Oct 3, 2022 · Completed: Oct 30, 2027
2 conditions5 sponsors1 location
NCT05411302
Augmenting Mental Health Support Through a Supportive Text Messaging Program
NARecruiting
1,500 participants
Started: Oct 3, 2022 · Completed: Sep 1, 2025
3 conditions3 sponsors1 location
NCT05586542
Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers
PHASE1Active, not recruiting
26 participants
Started: Oct 3, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor4 locations
NCT05396612
Role of the Immune Environment in Response to Therapy in Breast Cancer
N/ARecruiting
300 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2032
4 conditions1 sponsor1 location
NCT05355012
Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.
NARecruiting
4,505 participants
Started: Oct 3, 2022 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05530343
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
NARecruiting
2,298 participants
Started: Oct 3, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor14 locations
NCT05832528
Low FODMAP Diet in FD (PDS)
NARecruiting
30 participants
Started: Oct 3, 2022 · Completed: Feb 15, 2025
1 condition1 sponsor1 location
NCT04581590
The Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease
NAActive, not recruiting
242 participants
Started: Oct 3, 2022 · Completed: Feb 2, 2026
3 conditions2 sponsors1 location
NCT04353804
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III (RETURN-III)
PHASE2Recruiting
160 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors2 locations
NCT04901455
Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)
EARLY_PHASE1Recruiting
40 participants
Started: Oct 3, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05584384
The Use of tDCS in the Orofacial Pain
NARecruiting
40 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05141487
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
N/ARecruiting
16 participants
Started: Oct 3, 2022 · Completed: Oct 29, 2025
2 conditions1 sponsor1 location
NCT05582161
Efficacy Biomarkers of DAOIB for Dementia
PHASE2Recruiting
123 participants
Started: Oct 3, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor2 locations
NCT05289063
Vascular Endothelial Dysfunction in Sleep Apnea
PHASE1Recruiting
110 participants
Started: Oct 3, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05412433
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
NARecruiting
1,170 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT05578716
Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula
NARecruiting
312 participants
Started: Oct 3, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT05529901
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
N/AActive, not recruiting
300 participants
Started: Oct 3, 2022 · Completed: Aug 31, 2029
4 conditions1 sponsor1 location
NCT04827147
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
NAActive, not recruiting
64 participants
Started: Oct 3, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors8 locations
NCT05659901
Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease
N/ARecruiting
32 participants
Started: Oct 3, 2022 · Completed: Mar 31, 2029
1 condition1 sponsor4 locations
NCT05492422
Central Executive Training and Parent Training for ADHD
NARecruiting
200 participants
Started: Oct 3, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05397496
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
PHASE1Recruiting
140 participants
Started: Oct 3, 2022 · Completed: Jun 5, 2028
2 conditions1 sponsor21 locations
NCT05197855
Sleep Quality Evolution: Dreem Under CPAP
NARecruiting
70 participants
Started: Oct 3, 2022 · Completed: Dec 3, 2025
2 conditions3 sponsors1 location
NCT05537701
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)
N/AActive, not recruiting
316 participants
Started: Oct 3, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05280639
Simplified Post Op Rehabilitation for Ankle and Pilon Fractures
NARecruiting
30 participants
Started: Oct 3, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT04197193
Monitoring Antioxidant/Redox Status at Concordia (MARS-C)
N/AActive, not recruiting
30 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05570253
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
PHASE2Recruiting
55 participants
Started: Oct 3, 2022 · Completed: Oct 31, 2027
2 conditions2 sponsors10 locations
NCT05240924
ERP to Improve Functioning in Veterans With OCD
NARecruiting
160 participants
Started: Oct 3, 2022 · Completed: May 31, 2026
2 conditions1 sponsor18 locations
NCT05423145
Self-Administered Acupressure for Veterans With Chronic Back Pain
NARecruiting
300 participants
Started: Oct 3, 2022 · Completed: Nov 7, 2025
1 condition1 sponsor1 location
NCT05464264
Auditory MMN EEG in TRD in Response to Ketamine
N/ARecruiting
30 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT04892277
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
PHASE1Recruiting
25 participants
Started: Oct 3, 2022 · Completed: Mar 27, 2040
8 conditions1 sponsor1 location
NCT05179109
Robotic Versus Laparoscopic Surgery for Deep Endometriosis
NARecruiting
70 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06343181
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
N/ARecruiting
20 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05620888
Efficacy of a Tailored Communication Intervention Aimed At Increasing the Number of Daily Steps
NARecruiting
255 participants
Started: Oct 3, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05605912
Myosuit in Incomplete Spinal Cord Injury
NARecruiting
34 participants
Started: Oct 3, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06542718
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
N/ARecruiting
800 participants
Started: Oct 3, 2022 · Completed: Jul 1, 2026
6 conditions1 sponsor1 location
NCT05560750
Lingual Frenulum in Newborn Infants (LINNE)
NARecruiting
300 participants
Started: Oct 3, 2022 · Completed: Dec 31, 2028
4 conditions1 sponsor3 locations
NCT04086485
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
PHASE1/PHASE2Recruiting
56 participants
Started: Oct 3, 2022 · Completed: Jan 1, 2028
3 conditions1 sponsor1 location
NCT04592809
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
PHASE3Active, not recruiting
114 participants
Started: Oct 3, 2022 · Completed: Dec 1, 2026
3 conditions2 sponsors1 location